Literature DB >> 22609834

18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.

Yi-mei Du1, Cheng-kun Xia, Ning Zhao, Qian Dong, Ming Lei, Jia-hong Xia.   

Abstract

AIM: To compare the effects of two stereoisomeric forms of glycyrrhetinic acid on different components of Na(+) current, HERG and Kv1.5 channel currents.
METHODS: Wild-type (WT) and long QT syndrome type 3 (LQT-3) mutant ΔKPQ Nav1.5 channels, as well as HERG and Kv1.5 channels were expressed in Xenopus oocytes. In addition, isolated human atrial myocytes were used. Two-microelectrode voltage-clamp technique was used to record the voltage-activated currents.
RESULTS: Superfusion of 18β-glycyrrhetinic acid (18β-GA, 1-100 μmol/L) blocked both the peak current (I(Na,P)) and late current (I(Na,L)) generated by WT and ΔKPQ Nav1.5 channels in a concentration-dependent manner, while 18α-glycyrrhetinic acid (18α-GA) at the same concentrations had no effects. 18β-GA preferentially blocked I(Na,L) (IC(50)=37.2 ± 14.4 μmol/L) to I(Na,P) (IC(50)=100.4 ± 11.2 μmol/L) generated by ΔKPQ Nav1.5 channels. In human atrial myocytes, 18β-GA (30 μmol/L) inhibited 47% of I(Na,P) and 87% of I(Na,L) induced by Anemonia sulcata toxin (ATX-II, 30 nmol/L). Superfusion of 18β-GA (100 μmol/L) had no effects on HERG and Kv1.5 channel currents.
CONCLUSION: 18β-GA preferentially blocked the late Na current without affecting HERG and Kv1.5 channels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609834      PMCID: PMC4010371          DOI: 10.1038/aps.2012.22

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  38 in total

Review 1.  Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload.

Authors:  D Noble; P J Noble
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

2.  Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

Authors:  L Belardinelli; J C Shryock; H Fraser
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

3.  Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients.

Authors:  Nathalie H Nielsen; Bo G Winkel; Jørgen K Kanters; Nicole Schmitt; Jacob Hofman-Bang; Henrik S Jensen; Bo H Bentzen; Bjarne Sigurd; Lars A Larsen; Paal S Andersen; Stig Haunsø; Keld Kjeldsen; Morten Grunnet; Michael Christiansen; Søren-Peter Olesen
Journal:  Biochem Biophys Res Commun       Date:  2007-01-18       Impact factor: 3.575

4.  Pharmacological targeting of long QT mutant sodium channels.

Authors:  D W Wang; K Yazawa; N Makita; A L George; P B Bennett
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Blockade of gap junction coupling by glycyrrhetinic acids in guinea pig cochlear artery: a whole-cell voltage- and current-clamp study.

Authors:  B-C Guan; J-Q Si; Z-G Jiang
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

6.  Inhibition of mutagenicity in Salmonella typhimurium by Glycyrrhiza glabra extract, glycyrrhizinic acid, 18 alpha- and 18 beta-glycyrrhetinic acids.

Authors:  F Zani; M T Cuzzoni; M Daglia; S Benvenuti; G Vampa; P Mazza
Journal:  Planta Med       Date:  1993-12       Impact factor: 3.352

7.  Rapid kinetic interactions of ranolazine with HERG K+ current.

Authors:  Sridharan Rajamani; John C Shryock; Luiz Belardinelli
Journal:  J Cardiovasc Pharmacol       Date:  2008-06       Impact factor: 3.105

8.  Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Indira Jutooru; Alan McAlees; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2007-05       Impact factor: 6.261

Review 9.  Late sodium current inhibition as a new cardioprotective approach.

Authors:  Sharon L Hale; John C Shryock; Luiz Belardinelli; Michael Sweeney; Robert A Kloner
Journal:  J Mol Cell Cardiol       Date:  2008-04-08       Impact factor: 5.000

Review 10.  A history of the therapeutic use of liquorice in Europe.

Authors:  Cristina Fiore; Michael Eisenhut; Eugenio Ragazzi; Giorgio Zanchin; Decio Armanini
Journal:  J Ethnopharmacol       Date:  2005-07-14       Impact factor: 4.360

View more
  4 in total

1.  Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels.

Authors:  Zhen-Zhen Cao; You-Jia Tian; Jie Hao; Pei-Hua Zhang; Zhi-Pei Liu; Wan-Zhen Jiang; Meng-Liu Zeng; Pei-Pei Zhang; Ji-Hua Ma
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

Review 2.  Natural products modulating the hERG channel: heartaches and hope.

Authors:  Jadel M Kratz; Ulrike Grienke; Olaf Scheel; Stefan A Mann; Judith M Rollinger
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

3.  Inhibitory effects of glycyrrhetinic Acid on the delayed rectifier potassium current in Guinea pig ventricular myocytes and HERG channel.

Authors:  Delin Wu; Linqing Jiang; Hongjin Wu; Shengqi Wang; Sidao Zheng; Jiyuan Yang; Yuna Liu; Jianxun Ren; Xianbing Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-29       Impact factor: 2.629

4.  Gap junctions are essential for generating the correlated spike activity of neighboring retinal ganglion cells.

Authors:  Béla Völgyi; Feng Pan; David L Paul; Jack T Wang; Andrew D Huberman; Stewart A Bloomfield
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.